Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
04-2014 | 01-2014 | 10-2013 | 07-2013 | 04-2013 | |
Sales | 1,105 | 0 | 0 | 0 | 0 |
Gross Profit | 1,105 | N/A | N/A | N/A | N/A |
Operating Expenses | 2,460 | 1,965 | 2,164 | 2,219 | 1,851 |
Operating Income | -1,355 | -1,965 | -1,775 | -2,219 | -1,851 |
Interest Expense | 423 | 379 | 127 | 125 | 836 |
Other Income | -1,472 | -1,271 | -1,025 | -238 | 210 |
Pre-tax Income | -3,249 | -3,614 | -2,927 | -2,582 | -2,477 |
Net Income Continuous | -3,249 | -3,614 | -2,927 | -2,582 | -2,477 |
Net Income | $-3,249 | $-3,614 | $-2,927 | $-2,582 | $-2,477 |
EPS Basic Total Ops | -0.50 | -0.50 | -0.50 | -0.25 | -0.25 |
EPS Basic Continuous Ops | -0.38 | -0.43 | -0.36 | -0.32 | -0.32 |
EPS Diluted Total Ops | -0.50 | -0.50 | -0.50 | -0.25 | -0.25 |
EPS Diluted Continuous Ops | -0.38 | -0.43 | -0.36 | -0.32 | -0.32 |
EBITDA(a) | $-945 | $-1,591 | $-2,066 | $-2,127 | $-1,055 |